Clinical Trial Update: Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine [NA]

View source ↗

Summary

Clinical trial update exploring cytidine deaminase for patients with myelodysplastic syndromes or acute myeloid leukemia treated with azacitidine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Myeloid Leukemia, Myelodysplastic Syndromes | NA | Status: UNKNOWN